News & events

ABL AND IMUGENE PARTNER TO ADVANCE ONCOLYTIC VIRUS CANDIDATE TOWARDS LATER PHASE CLINICAL TRIALS

READ MORE

ABL AND ODIMMA THERAPEUTICS JOIN FORCES IN PERSONALIZED CANCER IMMUNOTHERAPY

Read more

ABL AND RD-BIOTECH SIGN STRATEGIC PARTNERSHIP IN CELL AND GENE THERAPY GMP MANUFACTURING

READ MORE

ABL PARTNERS WITH KALIVIR IMMUNOTHERAPEUTICS TO ADVANCE DEVELOPMENT OF ONCOLYTIC VIRUSES

Read more

COAVE THERAPEUTICS AND ABL ENTER INTO STRATEGIC COLLABORATION

Read more